- 英文名称
- Inokosterone
- 分子式
- C27H44O7
- 分子量
- 480.63
- 中文别名
- (2S,3R,5R,9R,10R,13R,17S)-2,3,14-三羟基-10,13-二甲基-17-((2R,3R)-2,3,7-三羟基-6-甲基庚烷-2-基)-2,3,4,5,9,11,12,13,14,15,16,17-十二氢-1H-环戊并[a]菲-6(10H)-酮; Β-牛膝甾酮; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R,6R)-2,3,7-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (2β,3β,5β,22R,25R)-2,3,14,20,22,26-Hexahydroxycholest-7-en-6-one; (22R,25R)-2beta,3beta,14,20,22,26-hexahydroxy-5beta-cholest-7-en-6-one; 25R-Inokosterone; Lnokosterone; 25-R inokosterone; (2beta,3beta,5beta,22R,25R)-2,3,14,20,22,26-Hexahydroxycholest-7-en-6-one; 5-beta-Cholest-7-en-6-one, 2-beta,3-beta,14,20,22,26-hexahydroxy-, (22R,25RS)-; Cholest-7-en-6-one, 2,3,14,20,22,26-hexahydroxy-, (2-beta,3-beta,5-beta,22R)-; (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1R,2R,5R)-1,2,6-trihydroxy-1,5-dimethyl-hexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one; (22R)-2β,3β,14,20,22,26-Hexahydroxy-5β-cholest-7-en-6-one; Cholest-7-en-6-one, 2,3,14,20,22,26-hexahydroxy-, (2β,3β,5β,22R)-; 7, (5α)-CHOLESTEN-2β, 3β, 14, 20R, 22S, 25R-6-ONE; 20(S)-Inokosterone
- 用途
- 牛膝甾酮是类风湿性关节炎患者雌激素受体1的潜在活性分子靶点；作为生命科学领域的中草药成分，用于相关研究或药物开发。
